| Omega-3 (n = 30) | Placebo (n = 30) |
---|---|---|
Age*, y | 48.6 ± 7.6 | 48.8 ± 8.7 |
Gender* | ||
 Male, n (%) | 9 (30) | 6 (20) |
 Female, n (%) | 21 (70) | 24 (80) |
Energy intake, kcal/d | 1585.1 ± 572.8 | 1200.2 ± 295.5 |
MET, (h/d) | 28.1 ± 4.2 | 27.7 ± 3.9 |
Height*, cm | 160.4 ± 8.9 | 160.5 ± 8.2 |
Weight*, kg | 78.0 ± 10.5 | 77.1 ± 12.5 |
BMI*, kg/m2 | 30.2 ± 3.6 | 29.8 ± 4.2 |
WC*, cm | 106.7 ± 9.1 | 104.2 ± 9.8 |
HDL-c*, mg/dL | 45.3 ± 8.9 | 46.5 ± 8.03 |
LDL-c*, mg/dL | 95.9 ± 30.0 | 92.2 ± 22.2 |
TG*, mg/dL | 151.6 ± 57.5 | 138.4 ± 51.8 |
TC*, mg/dL | 166.0 ± 41.1 | 159.9 ± 29.3 |
AIP* | 0.49 ± 0.22 | 0.44 ± 0.19 |
Castelli risk index I* | 3.63 ± 0.9 | 3.41 ± 0.7 |
Castelli risk index II* | 2.11 ± 0.6 | 1.97 ± 0.5 |
AC* | 2.63 ± 0.9 | 2.41 ± 0.7 |